Attachment F1
State Unintentional Drug Overdose Reporting System (SUDORS)
Introduction
This document displays the screens that abstractors use to enter required data elements for the SUDORS module. Each section of the module is shown separately, with a screenshot of the previous version on the left and the new version on the right. Variables that have not changed are indicated with black text with the same number on both the right and the left, and the corresponding variable name is given below the screenshot. Any new variables on the righthand side are flagged in red with additional numbers, and the corresponding variable names given below. Any changes are highlighted in a text box below both screenshots.
SUDORS Tab: Drug Overdose and Substance Abuse Sections
 
 Previous
SUDORS Version									Proposed SUDORS Version
Previous
SUDORS Version									Proposed SUDORS Version
	6 
	5 
	4 
	3 
	2 
	1 
 
 
 
 
 
 
 
                               
	5 
	4 
	3 
	2 
	1 
 
 
 
 
1 Typeofpoisoning
2 LastSeenAliveTime
3 LastSeenAliveMonth
4 LastSeenAliveDay
5 LastSeenAliveYear
1-5 Retained fields 6 SUDORSCase
 
 
 
	3 
	2 
	1 
 
 
	2 
	1 
 
	4 
 
	2a 
	4 
 
	2c 
	2b 
	3 
 
 
	2d 
	5 
 
 
	2e 
	2f 
	2g 
1 PreviousOverdose
 
2 TreatmentForSubstanceAbuse 2f SubsTx_NA
2a SubsTx_rehab 2g SubsTx_Other
2b SubsTx_MATcog 3 HistoryOpioid
2c SubsTx_MAT_nocog 4 RecentOpioidUse
2d SubsTx_MAT 5 RecentED
2e SubsTx_CogTherapy
	Changes to Drug Overdose and Substance Abuse Sections: 
	 Additional
		data element added to Drug Overdose/Poisoning section (#6) that
		allows the abstractor to identify unintentional/undetermined drug
		overdose deaths. This facilitates preliminary counts of drug
		overdose deaths 1
		additional question added to capture recent emergency department
		visit (#5). This identifies an opportunity for a public health
		intervention. 7 response
		categories added (#2a – #2g) that are designed to detect the
		type of substance abuse treatment the decedent received. This data
		can provide important data to treatment providers and public health
		officials tracking the effectiveness of different treatment
		approaches. 
		 
		
SUDORS Tab: Scene Indications of Drug Use Sections
Previous SUDORS Version Proposed SUDORS Version
 
 
 
	1a 
	4 
 
 
 
					
	1a 
	4a 
	1b 
 
 
	4 
	1b 
 
	4a 
	4c 
	4b 
	 
 
 
	4e 
	4d 
 
	4c 
	4b 
	 
 
	4d 
	5v 
	2 
 
	6 
	3 
 
	5v 
	2 
	3e 
	3a 
	7 
 
 
 
 
	7 
	6 
	3 
	3f 
	3b 
	8 
 
 
 
 
 
	8 
	3e 
	3a 
	3g 
	3c 
 
 
 
 
	10 
	9 
	3g 
	3f 
	3c 
	3b 
	3d 
	9 
 
 
 
 
 
 
 
	13 
	10 
 
	3d 
 
 
| 1a IndicationsDrugPara 1b IndicationsNone 2 RouteUnknown 3 RouteInjection 3a IndicationsTracks 3b HasEvidenceOfInjectionTourniquet 3c HasEvidenceOfInjectionCooker 3d HasEvidenceOfInjectionOther 3e HasEvidenceOfInjectionNeedle 3f HasEvidenceOfInjectionFilter 3g HasEvidenceOfInjectionWitnessReport 4 HasRapidOverdoseEvidence 4a IsTourniquetAroundArm 4b NeedleLocation 4c RapidOverdoseWitnessReport 4d RapidOverdoseOther 5 RouteSnorting 6 HasRouteSmoking 7 HasRouteTransdermal 8 RouteIngestion 9 RouteSuppository 10 HasRouteSublingual 11 HasEvidenceOfPrescriptionDrug 11a IsPrescribedToVictim 11b IndicationsRxDrugs 11c IsUnknownWhoPrescribed 11d IsPrescriptionPill 11e IsPrescriptionBottle 11f IsPrescriptionLozenge 11g HasEvidenceOfWitnessReportRxUse 11h IsPrescriptionOther 11i IsPrescriptionPatch 11j IsPrescriptionLiquid 11k IsPrescriptionVial 12 IndicationsDrugsatScene 12a HasEvidenceOfIllicitPowder 12b HasEvidenceOfIllicitWitnessReport 12c IsPrescriptionCounterfeit 12d HasEvidenceOfIllicitTar 12e HasEvidenceOfIllicitCrystal 12f IndicationsOther 
 
 | 1a IndicationsDrugPara 1b IndicationsNone 2 RouteUnknown 3 RouteInjection 3a IndicationsTracks 3b HasEvidenceOfInjectionTourniquet 3c HasEvidenceOfInjectionCooker 3d HasEvidenceOfInjectionOther 3e HasEvidenceOfInjectionNeedle 3f HasEvidenceOfInjectionFilter 3g HasEvidenceOfInjectionWitnessReport 4 HasRapidOverdoseEvidence 4a IsTourniquetAroundArm 4b NeedleLocation 4c RapidOverdoseWitnessReport 4d RapidOverdoseOther 4e BodyPosition 5 RouteSnorting 6 HasRouteSmoking 7 HasRouteTransdermal 8 RouteIngestion 9 RouteSuppository 10 HasRouteSublingual 11 HasEvidenceOfPrescriptionDrug 11a IsPrescribedToVictim 11b IndicationsRxDrugs 11c IsUnknownWhoPrescribed 11d IsPrescriptionPill 11e IsPrescriptionBottle 11f IsPrescriptionLozenge 11g HasEvidenceOfWitnessReportRxUse 11h IsPrescriptionOther 11i IsPrescriptionPatch 11j IsPrescriptionLiquid 11k IsPrescriptionVial 11L IsPrescriptionFentanyl 12 IndicationsDrugsatScene 12a HasEvidenceOfIllicitPowder 12b HasEvidenceOfIllicitWitnessReport 12c IsPrescriptionCounterfeit 12d HasEvidenceOfIllicitTar 12e HasEvidenceOfIllicitCrystal 12f IndicationsOther 12g HasEvidenceOfIllicitPackage 13 HasRouteBuccal | 
	Changes to Scene Indications of Drug Use Sections: 
	 For rapid
		overdoses (#4), the response option “body position”
		(#4e) was added based on feedback from medical examiner/coroners
		and SUDORS abstractors that rapid overdose could be determined by
		the position of the body. Buccal was
		added to route of drug administration (#13) because it was
		identified as a route in opioid overdose deaths that was not on the
		previous list. 
		 For
		evidence of illicit drug use (#12), illicit drug packaging (#12g)
		was added because it occurred in a sufficient number of drug
		overdose deaths to track. This will also improve the identification
		of drug overdose deaths involving illicit drugs. 
		 Scene or
		prescription evidence of fentanyl (#11L) was added because SUDORS
		abstractors indicated this information was available and it is
		critical to determine whether the fentanyl contributing to the
		overdose was prescribed versus illicitly manufactured. 
		
SUDORS Tab: Response to Drug Overdose and Medical History Sections
 
 
 Previous
SUDORS Version									Proposed SUDORS Version
Previous
SUDORS Version									Proposed SUDORS Version         
                                                                     
                                                     
 
	2 
	1 
	1 
 
 
 
	1l 
	1i 
	1f 
	1e 
	1a 
	1b 
	2 
 
 
 
 
 
 
 
 
	1m 
	1k 
	1j 
	1h 
	1g 
	1c 
	1d 
	13 
	9 
	3 
 
 
 
 
 
 
 
 
 
	18 
	14 
	10 
	4 
 
 
 
	20 
	19 
	16 
	15 
	11 
	5 
 
 
 
 
 
	17 
	12 
	6 
 
 
	7 
	21 
 
	8 
	23f 
	23e 
	23d 
	23c 
	23b 
	23a 
	30 
	29 
	28 
	27 
	26 
	25 
	24 
	22 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	8h 
	8i 
	8g 
	8l 
	8k 
	8j 
	8f 
	8e 
	8d 
	8c 
	8b 
	8a 
	8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
| 
 | 
 | 
 1a BystanderUser 1b BystanderPartner 1c BystanderFamily 1d BystanderFriend 1e BystanderStranger 1f BystanderRoomate 1g BystanderMedical 1h BystanderOther 1i BystanderCPR 1j BystanderBreathing 1k BystanderSternal 1l BystanderStim 1m BystanderIntOther 
 8a MedHx_COPD 8b MedHx_Asthma 8c MedHx_Apnea 8d MedHx_Heart 8e MedHx_Obesity 8f MedHx_Injury 8g MedHx_Migraine 8h MedHx_BackPain 8i MedHx_HepC 8k MedHx_OtherPain 8l MedHx_OtherBreathing | 
 22---HadPulse 23a FirstResponderCPR 23b FirstResponderBreathing 23c FirstResponderEpinephrine 23d FirstResponderED 23e FirstResponderOxygen 23f FirstResponderOther 
 | 
	Changes to Response to Drug Overdose and Medical History
	Sections: 8
		additional data elements (#1a – #1h) capture more detail on
		the bystanders of the fatal overdose. This information can be
		critical in allocating naloxone and other training resources to
		people who are likely to be present during fatal opioid overdoses. 6
		additional data elements (#1i – #1n) expand the list of
		bystander’s response to the overdose and emerge from state
		abstractors work on SUDORS. This will increase information on
		bystanders responses to fatal overdose and can inform training of
		bystanders likely to respond to overdoses. 12
		additional data elements capture information on decedent’s
		pre-existing conditions that: 1) may have contributed to the fatal
		overdose (#8a – #8e and #8l), 2) be related to injection drug
		use (#8i and #8j), or 3) explain the decedent’s use and/or
		prescription of opioid pain relievers (#8f – #8h and #8k). 
		 7
		additional data elements (#24 – #30) capture reasons
		bystander’s response to an overdose were delayed. Identifying
		these reasons can provide critical knowledge in improving responses
		to potentially fatal drug overdoses. 1
		additional data element (#22) was added to capture the condition of
		the decedent when first responders arrived. This informaiton is
		important because the appropriate medical response may vary
		depending on whether the decedent had a heart beat when first
		responders arrived. 6
		additional data elements (#23a – #23f) were added to capture
		the full array of treatments first responders administred to drug
		overdose decedents. This can inform training for future responses
		to potentially fatal drug overdoses. 
		
SUDORS Tab: Prescription Information Section
 Previous
SUDORS version										Proposed SUDORS version
Previous
SUDORS version										Proposed SUDORS version
 
 
	1 
	1 
 
 
	2 
	2 
 
	3 
	7 
	3 
 
	4 
	4 
 
	5 
	5 
 
	6 
	6 
 
| 
 | 
 7- FentanylRx | 
	Changes to Prescription Information Section: 1
		additional variable added to capture evidence that the decedent was
		prescribed fentanyl. This information is critical in determining
		whether the death was most likely linked with prescription fentanyl
		versus illicitly manufactured fentanyl. 
		
	
	
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document | 
| Author | Peterson, Alexis (CDC/ONDIEH/NCIPC) | 
| File Modified | 0000-00-00 | 
| File Created | 2021-01-15 |